5.0E-4 (1.176%)
ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/A
Telephone
61.3.9653.9160
Address
Suite 1 Level 9 432 St Kilda Road Melbourne, Victoria (VIC) 3004
Description
Vitasora Health Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. The firm operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.1
Trade Value (12mth)
AU$12,670.00
1 week
11.84%
1 month
14.86%
YTD
-46.2%
1 year
28.79%
All time high
131.49
EPS 3 yr Growth
-55.70%
EBITDA Margin
%
Operating Cashflow
-$7m
Free Cash Flow Return
-365.10%
ROIC
-392.00%
Interest Coverage
-116.70
Quick Ratio
0.40
Shares on Issue (Fully Dilluted)
1213m
HALO Sector
Healthcare
Next Company Report Date
02-Sep-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
29 May 25 |
Upcoming Expiry of Listed Options
×
Upcoming Expiry of Listed Options |
|
28 May 25 |
Cleansing Prospectus
×
Cleansing Prospectus |
|
27 May 25 |
Release of Shares from Escrow
×
Release of Shares from Escrow |
|
26 May 25 |
Vitasora USA Momentum- Virtual Briefing on Key Developments
×
Vitasora USA Momentum- Virtual Briefing on Key Developments |
|
20 May 25 |
Change of Directors' Interest Notices x2
×
Change of Directors' Interest Notices x2 |
|
16 May 25 |
Application for quotation of securities - VHL
×
Application for quotation of securities - VHL |
|
16 May 25 |
Section 708A Cleansing Notice
×
Section 708A Cleansing Notice |
|
29 April 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
|
24 April 25 |
Change of OTC Ticker
×
Change of OTC Ticker |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
